Search
for
Sort by
Research 691–720 of 1000+
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Complete Pseudo-Anodontia in an Adult Woman with Pseudo-Hypoparathyroidism Type 1a: A New Additional Nonclassical Feature?
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Symptom Trajectories and Long-Term Sequelae of COVID-19: A Matched Case–Control Study with Population-Based Controls
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Semaglutide and the Skin: An Overview of Current Evidence
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
- Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- Profile of Female Hyperandrogenism at the Medical Clinic II: About 19 Cases
- Defective Expression of the Gap Junction Protein Pannexin-1 Channel Contributes to the Formation of PCOS-Realted Androgenetic Alopecia
- Blood group O and post-COVID-19 syndrome
- AKT2 Gene Polymorphisms, sRANKL/OPG and Hormone Measurements in Polycystic Ovarian Syndrome (PCOS) Women
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression
- Androgen excess: a hallmark of polycystic ovary syndrome